Capital International Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78M | Buy |
175,233
+44,008
| +34% | +$19.6M | 0.76% | 35 |
|
|
2025
Q1 | $63.6M | Buy |
131,225
+7,091
| +6% | +$3.44M | 0.77% | 30 |
|
|
2024
Q4 | $50M | Buy |
124,134
+13,781
| +12% | +$5.55M | 0.59% | 47 |
|
|
2024
Q3 | $51.3M | Buy |
110,353
+4,171
| +4% | +$1.94M | 0.65% | 45 |
|
|
2024
Q2 | $49.8M | Buy |
106,182
+7,657
| +8% | +$3.59M | 0.66% | 41 |
|
|
2024
Q1 | $41.2M | Buy |
98,525
+20,482
| +26% | +$8.56M | 0.56% | 56 |
|
|
2023
Q4 | $31.8M | Buy |
78,043
+16,102
| +26% | +$6.55M | 0.5% | 57 |
|
|
2023
Q3 | $21.5M | Buy |
61,941
+5,552
| +10% | +$1.93M | 0.41% | 74 |
|
|
2023
Q2 | $19.8M | Buy |
56,389
+17,771
| +46% | +$6.25M | 0.36% | 79 |
|
|
2023
Q1 | $12.2M | Buy |
38,618
+1,187
| +3% | +$374K | 0.24% | 109 |
|
|
2022
Q4 | $10.8M | Sell |
37,431
-5,379
| -13% | -$1.55M | 0.23% | 119 |
|
|
2022
Q3 | $12.4M | Sell |
42,810
-16,624
| -28% | -$4.81M | 0.28% | 105 |
|
|
2022
Q2 | $16.7M | Sell |
59,434
-622
| -1% | -$175K | 0.23% | 124 |
|
|
2022
Q1 | $15.7M | Sell |
60,056
-47,117
| -44% | -$12.3M | 0.18% | 134 |
|
|
2021
Q4 | $23.5M | Buy |
107,173
+13,572
| +14% | +$2.98M | 0.22% | 123 |
|
|
2021
Q3 | $17M | Sell |
93,601
-21,698
| -19% | -$3.94M | 0.16% | 135 |
|
|
2021
Q2 | $23.2M | Sell |
115,299
-644
| -0.6% | -$130K | 0.21% | 125 |
|
|
2021
Q1 | $24.9M | Sell |
115,943
-101,543
| -47% | -$21.8M | 0.23% | 119 |
|
|
2020
Q4 | $51.4M | Buy |
217,486
+1,545
| +0.7% | +$365K | 0.48% | 78 |
|
|
2020
Q3 | $58.8M | Buy |
215,941
+11,780
| +6% | +$3.21M | 0.65% | 53 |
|
|
2020
Q2 | $59.3M | Buy |
204,161
+42,547
| +26% | +$12.4M | 0.72% | 44 |
|
|
2020
Q1 | $38.5M | Buy |
161,614
+22,414
| +16% | +$5.33M | 0.65% | 64 |
|
|
2019
Q4 | $30.5M | Buy |
+139,200
| New | +$30.5M | 0.42% | 92 |
|
|
2019
Q3 | – | Sell |
-19,615
| Closed | -$3.6M | – | 246 |
|
|
2019
Q2 | $3.6M | Buy |
+19,615
| New | +$3.6M | 0.25% | 93 |
|